IR
Superintel
OverviewMarketsWatchlist
© 2026 IR SuperintelMethodologyContact

Veraxa Biotech AG

CUSIP: H9130A111 | 29 institutional holders

Quarters

Q3 2026Q2 2026
CompareDetailedHistoricalFundsOptionsShort Interest13D/13GPeersTargetingTrading SummaryProfile

Beneficial Ownership — 13D / 13G

Full history →

5%+ stakes reported outside the quarterly cycle. A 13D is due within five business days of the event below, so these figures lead the holders table until the filer's next 13F catches up to them.

HolderShares% of ClassChangeEvent Datevs 13F
13DDeck David Lukas25,502,83618.0%New 5%+ stakeJun 10, 2026No 13F filer matched
13DXlife Sciences AG23,029,96716.3%New 5%+ stakeJun 10, 2026

Institutional Holders — Q3 2026

Alberta Investment Management Corp875,000
0.0% of portfolio›$52.6K
Picton Mahoney Asset Management175,000
0.0% of portfolio›$10.5K
Context Capital Management, LLC100,000
0.0% of portfolio›$6.0K
Wolverine Asset Management LLC6,953
0.0% of portfolio›$418
StyleTurnoverLocationFiled
Alberta Investment Management Corp
875,000$52.6K0.0%ValueHighEdmonton, Abu Dhabi2026-11-09
Picton Mahoney Asset Management
175,000$10.5K0.0%GARPHighToronto, Australia2026-11-09
Context Capital Management, LLC
100,000$6.0K0.0%GrowthHighGreenwich, CT2026-11-04
Wolverine Asset Management LLC
6,953$4180.0%Deep ValueVery HighChicago, IL2026-11-02
No 13F filer matched
13DEuropean Molecular Biology Laboratory22,891,23516.2%New 5%+ stakeJun 10, 2026No 13F filer matched
13DSchoeni Gilbert Edgar22,539,74915.9%New 5%+ stakeJun 10, 2026No 13F filer matched
13DDeck David Lukas25,502,836
18.0% of class · Jun 10, 2026New 5%+ stake
No 13F filer matched
13DXlife Sciences AG23,029,967
16.3% of class · Jun 10, 2026New 5%+ stake
No 13F filer matched
13DEuropean Molecular Biology Laboratory22,891,235
16.2% of class · Jun 10, 2026New 5%+ stake
No 13F filer matched
13DSchoeni Gilbert Edgar22,539,749
15.9% of class · Jun 10, 2026New 5%+ stake
No 13F filer matched